On Friday, Shares of Meritor Inc (NYSE:MTOR), added 4.35% and closed at $11.76 in the last trading session. The last trading range of the stock ranges between $11.30 and $11.77. Meritor, Inc. designs, develops, manufactures, markets, distributes, sells, services, and supports integrated systems, modules, and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors worldwide. It operates through two segments, Commercial Truck & Industrial; and Aftermarket & Trailer. The Commercial Truck & Industrial segment supplies drivetrain systems and components, counting axles, drivelines, and braking and suspension systems mainly for medium-and heavy-duty trucks, off-highway, military, construction, bus and coach, fire and emergency, and other applications. The Aftermarket & Trailer segment supplies axles, brakes, drivelines, suspension parts, and other replacement and remanufactured parts to commercial vehicle aftermarket customers. This segment also offers various undercarriage products and systems for trailer applications.
YPF SA (ADR)(NYSE:YPF), dropped -0.62% and closed at $16.00 in the last trading session. The last trading range of the stock ranges between $15.58 and $16.14. The company’s Market capitalization is $6.20 Billion with the total Outstanding Shares of 393.14 million. YPF S.A., an energy company, operates in the oil and gas upstream and downstream activities in Argentina. It engages in the exploration, development, and production of crude oil, natural gas, and liquefied petroleum gas (LPG). The company is also involved in the refining, marketing, transportation, and distribution of oil, petroleum products, petroleum derivatives, petrochemicals, LPG, and bio-fuels, in addition to in gas separation and natural gas distribution operations. As of December 31, 2015, it had interests in about 108 oil and gas fields; proved reserves of about 679 million barrels (mmbbl) of oil; and about 3,072 billion cubic feet of gas. The company also had a retail distribution network of 1,538 YPF-branded service stations; 38 exploration permits, counting 34 onshore and 4 offshore exploration permits, in addition to 108 production concessions; and 31 crude oil treatment plants and 7 pumping plants. In addition, it owns 3 refineries with annual refining capacity of about 116 mmbbl; about 2,700 kilometers of crude oil pipelines with about 640,000 barrels of aggregate daily transportation capacity of refined products; and crude oil tankage of about 7 mmbbl, in addition to maintains terminal facilities at 5 Argentine ports. In Addition To, the company take parts in 3 power generation plants with an aggregate installed capacity of 1,622 megawatts; provides telecommunications services; and engages in the production, industrialization, processing, marketing, preparation, transportation, and storage of grains and its derivatives.
Illumina, Inc. (NASDAQ:ILMN), dropped -0.55% and closed at $137.60 in the last trading session. The last trading range of the stock ranges between $136.75 and $140.87.The company stock’s 52-week range is $127.10 – $196.47. Illumina, Inc. (ILMN) recently declared it has entered a contract with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo’s delivery of genetic and genomic expertise.
Together, the organizations plan to integrate existing services and software tools and employ new, innovative solutions to improve Mayo Clinic’s reporting workflows for researching inherited disease, enabling Illumina to develop an informatics platform and knowledge base that can improve and automate genomic interpretation.
As part of the agreement, Mayo Clinic will implement BaseSpace Clarity LIMS in specific laboratories to provide testing of the tool. BaseSpace Clarity LIMS is a system to provide comprehensive workflow tracking and integration in laboratories. Mayo Clinic will also deploy and provide feedback on its use of BaseSpace Sequence Hub, a cloud-based genomics computing environment for data analysis and administration, and BaseSpace Variant Interpreter, a cloud-based interpretation and reporting platform designed to decrease the time and effort required to assess biological insight from genomic data. The software solutions will be piloted by Mayo Clinic to annotate and interpret genetic variants with regard to their potential role in the development and progression of diseases.